{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:18:48Z","timestamp":1769242728258,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Hellenic Airforce General Staff, Hellenic Airforce"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.11.021","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T18:51:39Z","timestamp":1574362299000},"page":"1181-1185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vaccination coverage and immunity levels against vaccine-preventable diseases in male Air Force recruits in Greece"],"prefix":"10.1016","volume":"38","author":[{"given":"Helena C.","family":"Maltezou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heleni","family":"Karantoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Petrikkos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Persephoni","family":"Georgota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panos","family":"Katerelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aikaterini","family":"Liona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanos","family":"Tsagarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Theodoridou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Hatzigeorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.11.021_b0005","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1056\/NEJMms1215400","article-title":"Contagious diseases in the United States from 1888 to the present","volume":"369","author":"Van Panhuis","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.11.021_b0010","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1016\/j.vaccine.2019.05.095","article-title":"Mandatory vaccinations for children in Italy: the need for a stable frame","volume":"37","author":"Maltezou","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.021_b0015","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(18)32031-2","article-title":"41,000 measles cases in Europe since the beginning of 2018","volume":"392","author":"Holt","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.11.021_b0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cmi.2017.04.008","article-title":"Eliminating measles and rubella in Europe","volume":"23","author":"Allerberger","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.021_b0025","unstructured":"European Centre for Disease Prevention and Control. Monthly measles and rubella monitoring report. Available at: <https:\/\/www.ecdc.europa.eu\/sites\/portal\/files\/documents\/monthly-measles-rubella-monitoring-report-april-2019.pdf> [last accessed: October 26, 2019]."},{"key":"10.1016\/j.vaccine.2019.11.021_b0030","doi-asserted-by":"crossref","unstructured":"Ndumbi P, Freidl GS, Williams CJ, M\u00e5rdh O, Varela C, Avell\u00f3n A, et al. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and the European Economic Area, June 2016 to May 2017. Euro Surveill 2018;23(33).","DOI":"10.2807\/1560-7917.ES.2018.23.33.1700641"},{"key":"10.1016\/j.vaccine.2019.11.021_b0035","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S0950268809991257","article-title":"An outbreak of hepatitis A in Roma populations living in three prefectures in Greece","volume":"138","author":"Vantarakis","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.021_b0040","article-title":"Considerations on the current universal vaccination policy against hepatitis A in Greece after recent outbreaks","volume":"10.e0116939","author":"Mellou","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.021_b0045","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1017\/S0950268818002170","article-title":"Ongoing measles outbreak in Greece related to the recent European-wide epidemic","volume":"146","author":"Georgakopoulou","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.021_b0050","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1016\/j.vaccine.2014.06.031","article-title":"Vaccination coverage and susceptibility against vaccine-preventable diseases of healthcare students in Athens, Greece","volume":"32","author":"Karageorgou","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.021_b0055","unstructured":"European Commission. Eurostat. NUTS-Nomenclature for territorial units for statistics. Available at: <https:\/\/ec.europa.eu\/eurostat\/web\/nuts\/background> [last accessed: October 26, 2019]."},{"key":"10.1016\/j.vaccine.2019.11.021_b0060","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019. Available at: <http:\/\/www.R-project.org\/> [last accessed: October 26, 2019]."},{"key":"10.1016\/j.vaccine.2019.11.021_b0065","unstructured":"Hellenic Statistical Authority. Population census. Available at: <http:\/\/www.statistics.gr\/> [last accessed: October 26, 2019]."},{"key":"10.1016\/j.vaccine.2019.11.021_b0070","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1473-3099(15)00053-5","article-title":"Dangers of vaccine refusal near the herd immunity threshold: a modelling study","volume":"15","author":"Fefferman","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.021_b0075","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/j.jhin.2018.06.007","article-title":"Measles in healthcare workers during the ongoing epidemic in Greece, 2017\u20132018","volume":"100","author":"Maltezou","year":"2018","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.vaccine.2019.11.021_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216219","article-title":"Seroepidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia","volume":"14","author":"Ristic","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.021_b0085","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268819000050","article-title":"Measles and rubella seroprevalence in a population of young adult blood donors, France 2013","volume":"147","author":"Antona","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.021_b0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2334-6-163","article-title":"Serologic indices of hepatitis B virus infection in military recruits in Greece (2004\u20132005)","volume":"6","author":"German","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.021_b0095","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1017\/S0950268817001546","article-title":"A systemic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data","volume":"145","author":"Bollaerts","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.021_b0100","unstructured":"Funk S. Critical immunity thresholds for measles elimination. London School of Hygiene and Tropical Medicine (19 October, 2017). Available at: <https:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/2._target_immunity_levels_FUNK.pdf> [last accessed: October 26, 2019]."},{"key":"10.1016\/j.vaccine.2019.11.021_b0105","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.vaccine.2018.04.036","article-title":"Assessing population immunity for measles elimination \u2013 the promise and peril of serosurveys","volume":"36","author":"Durrheim","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.021_b0110","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1007\/s00705-019-04369-9","article-title":"Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity","volume":"164","author":"Pond\u00e9","year":"2019","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2019.11.021_b0115","article-title":"Emerging hepatitis B virus infection in vaccinated populations: a rising concern?","volume":"1","author":"Tung-Hung","year":"2012","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2019.11.021_b0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/vim.2017.0143","article-title":"Measles vaccine","volume":"31","author":"Griffin","year":"2018","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2019.11.021_b0125","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/516657","article-title":"Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease","volume":"28","author":"Trevisan","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2019.11.021_b0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajic.2007.04.283","article-title":"Diphtheria, tetanus, and varicella immunity in health care workers in neonatal units","volume":"36","author":"dos Santos","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2019.11.021_b0135","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.vaccine.2004.10.003","article-title":"Garc\u00eda de Codes A. Seroprevalence of varicella antibodies in healthcare workers and health science students. Reliability of self-reported history of varicella","volume":"23","author":"De Juanes","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.021_b0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2458-8-121","article-title":"Reliability of medical students' vaccination histories for immunisable diseases","volume":"8","author":"Wicker","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.11.021_b0145","unstructured":"National School of Public Health. National Study of Vaccination Coverage of Children in Greece; 2012. Available at: <http:\/\/www.esdy.edu.gr\/files\/011_Ygeias_Paidiou\/Ereunes\/ekthesi_emvolia_2012.pdf> [last accessed: October 26, 2019]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:41:49Z","timestamp":1759401709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19315440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19315440"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination coverage and immunity levels against vaccine-preventable diseases in male Air Force recruits in Greece","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}